US Stock MarketDetailed Quotes

Cue Biopharma (CUE)

Watchlist
  • 27.860
  • -2.580-8.48%
Close Jun 10 16:00 ET
117.02MMarket Cap-6.15P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cue Biopharma (CUE) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
1,250.59%5.69M
195.75%27.47M
1,292.26%21.94M
-35.58%2.15M
11.14%2.95M
-75.48%421K
69.16%9.29M
-13.45%1.58M
58.86%3.34M
92.33%2.66M
Operating revenue
1,250.59%5.69M
195.75%27.47M
1,292.26%21.94M
-35.58%2.15M
11.14%2.95M
-75.48%421K
69.16%9.29M
-13.45%1.58M
58.86%3.34M
92.33%2.66M
Cost of revenue
Gross profit
Operating expense
-13.14%11.05M
6.11%53.99M
78.35%19.98M
-20.86%9.69M
-11.13%11.59M
-11.57%12.72M
-11.49%50.88M
-27.69%11.21M
-9.40%12.25M
-12.47%13.04M
Selling and administrative expenses
-0.50%4.15M
11.37%16.24M
-14.15%3.45M
72.27%4.94M
4.85%3.68M
-0.31%4.17M
-12.56%14.59M
-12.76%4.02M
-21.34%2.87M
-17.51%3.51M
-General and administrative expense
-0.50%4.15M
11.37%16.24M
-14.15%3.45M
72.27%4.94M
4.85%3.68M
-0.31%4.17M
-12.56%14.59M
-12.76%4.02M
-21.34%2.87M
-17.51%3.51M
Research and development costs
-19.31%6.9M
3.99%37.74M
130.12%16.53M
-49.32%4.75M
-17.00%7.91M
-16.20%8.55M
-11.05%36.3M
-34.01%7.18M
-4.99%9.38M
-10.52%9.53M
Depreciation amortization depletion
----
----
----
----
-33.33%4K
----
----
----
----
--6K
-Depreciation and amortization
----
----
----
----
-33.33%4K
----
----
----
----
--6K
Operating profit
56.39%-5.36M
36.24%-26.52M
120.33%1.96M
15.35%-7.54M
16.84%-8.64M
2.91%-12.3M
20.00%-41.59M
29.59%-9.63M
21.95%-8.91M
23.19%-10.38M
Net non-operating interest income expense
316.67%175K
-45.52%450K
-21.90%107K
-5.16%147K
-27.83%153K
-86.92%42K
-41.67%826K
-65.58%137K
-62.56%155K
-36.14%212K
Non-operating interest income
5.29%179K
-50.25%807K
-45.52%158K
-35.28%222K
-53.63%198K
-69.75%170K
-39.05%1.62M
-67.96%290K
-51.00%343K
-24.29%427K
Non-operating interest expense
-96.88%4K
-55.15%357K
-66.67%51K
-60.11%75K
-79.07%45K
-46.89%128K
-36.06%796K
-69.82%153K
-34.27%188K
-7.33%215K
Other net income (expense)
10K
-133.33%-31K
600.00%20K
-152.58%-51K
159.24%93K
-4K
97K
Special income (charges)
--10K
-133.33%-31K
600.00%20K
-152.58%-51K
----
--0
159.24%93K
97.45%-4K
--97K
----
-Less:Other special charges
---10K
----
----
----
----
----
----
----
----
----
-Gain on sale of property,plant,equipment
----
-133.33%-31K
600.00%20K
-152.58%-51K
----
----
159.24%93K
97.45%-4K
--97K
----
Income before tax
57.75%-5.18M
35.83%-26.1M
121.96%2.09M
14.00%-7.45M
16.61%-8.48M
0.73%-12.26M
19.83%-40.67M
29.31%-9.5M
21.31%-8.66M
22.86%-10.17M
Income tax
500K
0
Net income
57.75%-5.18M
34.60%-26.6M
116.69%1.59M
14.00%-7.45M
16.61%-8.48M
0.73%-12.26M
19.83%-40.67M
29.31%-9.5M
21.31%-8.66M
22.86%-10.17M
Net income continuous Operations
57.75%-5.18M
34.60%-26.6M
116.69%1.59M
14.00%-7.45M
16.61%-8.48M
0.73%-12.26M
19.83%-40.67M
29.31%-9.5M
21.31%-8.66M
22.86%-10.17M
Minority interest income
Net income attributable to the parent company
57.75%-5.18M
34.60%-26.6M
116.69%1.59M
14.00%-7.45M
16.61%-8.48M
0.73%-12.26M
19.83%-40.67M
29.31%-9.5M
21.31%-8.66M
22.86%-10.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
57.75%-5.18M
34.60%-26.6M
116.69%1.59M
14.00%-7.45M
16.61%-8.48M
0.73%-12.26M
19.83%-40.67M
29.31%-9.5M
21.31%-8.66M
22.86%-10.17M
Basic earnings per share
78.18%-1.08
61.11%-8.4
107.69%0.3
58.82%-2.1
55.00%-2.7
34.00%-4.95
35.14%-21.6
55.17%-3.9
29.17%-5.1
31.03%-6
Diluted earnings per share
78.18%-1.08
61.11%-8.4
107.69%0.3
58.82%-2.1
55.00%-2.7
34.00%-4.95
35.14%-21.6
55.17%-3.9
29.17%-5.1
31.03%-6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 1,250.59%5.69M195.75%27.47M1,292.26%21.94M-35.58%2.15M11.14%2.95M-75.48%421K69.16%9.29M-13.45%1.58M58.86%3.34M92.33%2.66M
Operating revenue 1,250.59%5.69M195.75%27.47M1,292.26%21.94M-35.58%2.15M11.14%2.95M-75.48%421K69.16%9.29M-13.45%1.58M58.86%3.34M92.33%2.66M
Cost of revenue
Gross profit
Operating expense -13.14%11.05M6.11%53.99M78.35%19.98M-20.86%9.69M-11.13%11.59M-11.57%12.72M-11.49%50.88M-27.69%11.21M-9.40%12.25M-12.47%13.04M
Selling and administrative expenses -0.50%4.15M11.37%16.24M-14.15%3.45M72.27%4.94M4.85%3.68M-0.31%4.17M-12.56%14.59M-12.76%4.02M-21.34%2.87M-17.51%3.51M
-General and administrative expense -0.50%4.15M11.37%16.24M-14.15%3.45M72.27%4.94M4.85%3.68M-0.31%4.17M-12.56%14.59M-12.76%4.02M-21.34%2.87M-17.51%3.51M
Research and development costs -19.31%6.9M3.99%37.74M130.12%16.53M-49.32%4.75M-17.00%7.91M-16.20%8.55M-11.05%36.3M-34.01%7.18M-4.99%9.38M-10.52%9.53M
Depreciation amortization depletion -----------------33.33%4K------------------6K
-Depreciation and amortization -----------------33.33%4K------------------6K
Operating profit 56.39%-5.36M36.24%-26.52M120.33%1.96M15.35%-7.54M16.84%-8.64M2.91%-12.3M20.00%-41.59M29.59%-9.63M21.95%-8.91M23.19%-10.38M
Net non-operating interest income expense 316.67%175K-45.52%450K-21.90%107K-5.16%147K-27.83%153K-86.92%42K-41.67%826K-65.58%137K-62.56%155K-36.14%212K
Non-operating interest income 5.29%179K-50.25%807K-45.52%158K-35.28%222K-53.63%198K-69.75%170K-39.05%1.62M-67.96%290K-51.00%343K-24.29%427K
Non-operating interest expense -96.88%4K-55.15%357K-66.67%51K-60.11%75K-79.07%45K-46.89%128K-36.06%796K-69.82%153K-34.27%188K-7.33%215K
Other net income (expense) 10K-133.33%-31K600.00%20K-152.58%-51K159.24%93K-4K97K
Special income (charges) --10K-133.33%-31K600.00%20K-152.58%-51K------0159.24%93K97.45%-4K--97K----
-Less:Other special charges ---10K------------------------------------
-Gain on sale of property,plant,equipment -----133.33%-31K600.00%20K-152.58%-51K--------159.24%93K97.45%-4K--97K----
Income before tax 57.75%-5.18M35.83%-26.1M121.96%2.09M14.00%-7.45M16.61%-8.48M0.73%-12.26M19.83%-40.67M29.31%-9.5M21.31%-8.66M22.86%-10.17M
Income tax 500K0
Net income 57.75%-5.18M34.60%-26.6M116.69%1.59M14.00%-7.45M16.61%-8.48M0.73%-12.26M19.83%-40.67M29.31%-9.5M21.31%-8.66M22.86%-10.17M
Net income continuous Operations 57.75%-5.18M34.60%-26.6M116.69%1.59M14.00%-7.45M16.61%-8.48M0.73%-12.26M19.83%-40.67M29.31%-9.5M21.31%-8.66M22.86%-10.17M
Minority interest income
Net income attributable to the parent company 57.75%-5.18M34.60%-26.6M116.69%1.59M14.00%-7.45M16.61%-8.48M0.73%-12.26M19.83%-40.67M29.31%-9.5M21.31%-8.66M22.86%-10.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 57.75%-5.18M34.60%-26.6M116.69%1.59M14.00%-7.45M16.61%-8.48M0.73%-12.26M19.83%-40.67M29.31%-9.5M21.31%-8.66M22.86%-10.17M
Basic earnings per share 78.18%-1.0861.11%-8.4107.69%0.358.82%-2.155.00%-2.734.00%-4.9535.14%-21.655.17%-3.929.17%-5.131.03%-6
Diluted earnings per share 78.18%-1.0861.11%-8.4107.69%0.358.82%-2.155.00%-2.734.00%-4.9535.14%-21.655.17%-3.929.17%-5.131.03%-6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.23%
Sample Name
Sample Code
 +1.31%
Sample Name
Sample Code
 -1.03%
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-2.32%
5
ProShares UltraShort Energy
DUG
-2.99%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +2.95%
Sample Name
Sample Code
 +1.98%
Sample Name
Sample Code
 +1.29%
4
Tencent Music
TME
+0.77%
5
Zai Lab
ZLAB
+0.52%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Tensions in the Middle East continue to escalate. After Iran shot down a U.S. Apache helicopter, the U.S. military launched retaliatory airs Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -